[Acute bacterial parotitis caused by Serratia marcescens].
Domínguez Herrera
J M
JM
Jiménez Mejías
M E
ME
Infante Cossio
P
P
Hernández Guisado
J M
JM
D000208:Acute Disease; D001398:Aztreonam / Q000008:administration & dosage / Q000627:therapeutic use; D002439:Cefotaxime / Q000008:administration & dosage / Q000627:therapeutic use; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008875:Middle Aged; D008997:Monobactams / Q000008:administration & dosage / Q000627:therapeutic use; D010309:Parotitis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D016868:Serratia Infections / Q000188:drug therapy; D012706:Serratia marcescens / Q000302:isolation & purification; D013997:Time Factors; D014057:Tomography, X-Ray Computed
D002511:Cephalosporins; D008997:Monobactams; D001398:Aztreonam; D002439:Cefotaxime
Parotiditis aguda bacteriana por Serratia marcescens.